Axceler8 Rx: AI Precision for Clinical Trial Acceleration
A next-generation analytics platform built by Arthur D. Little & Vega IT, delivering measurable speed, accuracy, and control across clinical development.
Already used by leading pharma study teams to accelerate feasibility, startup, and enrollment.
Voices from the frontlines of clinical trials
Strong work. I’m truly impressed by the collaboration and input from so many contributors to bring this together. Reviewing the results put a huge smile on my face this morning!
Thank you for this view that places all scenarios into one simple, easy-to-digest view. This will be extremely helpful for upcoming strategic discussions with senior leadership to determine the optimal study footprint and understand tradeoffs.
The additional site selection list helped us mitigate the high volume of declines during SFQ with our original list, as we pushed toward adding ~100 more sites.
Many thanks for the efficient turnaround with these targeted analyses. The message was clear — even with a 30% faster activation rate, overall last-patient-in barely moves. That clarity has helped our leadership focus on the right levers.”
Very useful information on the deep-dive rationale for site and country-specific rating in Portugal, as we consider additional high-potential countries in Europe. Thank you very much.
Thank you for the close collaboration over the past weeks to deliver semi-bottom-up projections for the critical lymphoma study.
Quantified, Proven Acceleration
End-to-end Unified Acceleration Intelligence
Axceler8 Rx uses real-world trial data, AI analytics, and operational expertise from Arthur D. Little in a connected command center developed by Vega IT for clinical trial acceleration.
It replaces static spreadsheets and fragmented trackers with predictive tools that show, in real time, how to reach milestones faster.
Supporting smarter, more predictable clinical trials
About the team
Axceler8 Rx is developed and delivered by Arthur D. Little, the world’s first management consultancy and a recognized leader in clinical-trial acceleration together with Vega IT - a digital product development and system integration company with global experience in delivering innovative digital solutions in the healthcare industry in more than 25 countries.
Our team includes clinical operations veterans, data scientists, and AI engineers who have delivered measurable acceleration across oncology, neurology, immunology, cardiology, and rare disease studies.
Bring Predictive Intelligence to Your Next Study
Discover how Axceler8 Rx can transform feasibility, forecasting, and execution with proven analytics and expert support.
